ArticleJournal of clinical medicine2019

Phosphoproteomic Profiling Identifies Aberrant Activation of Integrin Signaling in Aggressive Non-Type Bladder Carcinoma.

Barnali Deb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.